Comparison of stereotactic body radiation therapy with and without sorafenib as treatment for hepatocellular carcinoma with portal vein tumor thrombosis

Stereotactic body radiation therapy (SBRT) has emerged as a treatment option for unresectable hepatocellular carcinoma (HCC) patients. However, the treatment outcomes for patients with portal vein tumor thrombosis (PVTT) remain poor. In this study, we evaluate the efficacy of SBRT with and or withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Que, Jenny, Wu, Hung-Chang, Lin, Chia-Hui, Huang, Chung-I, Li, Li-Ching, Ho, Chung-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220154/
https://www.ncbi.nlm.nih.gov/pubmed/32221093
http://dx.doi.org/10.1097/MD.0000000000019660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220154/
https://www.ncbi.nlm.nih.gov/pubmed/32221093
http://dx.doi.org/10.1097/MD.0000000000019660

Ejemplares similares